ID NB5R2_DANRE Reviewed; 309 AA. AC Q0P487; A2CET6; DT 15-MAY-2007, integrated into UniProtKB/Swiss-Prot. DT 15-MAY-2007, sequence version 2. DT 16-JUN-2009, entry version 29. DE RecName: Full=NADH-cytochrome b5 reductase 2; DE Short=b5R.2; DE EC=1.6.2.2; GN Name=cyb5r2; ORFNames=si:dkey-80c24.9, zgc:153291; OS Danio rerio (Zebrafish) (Brachydanio rerio). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes; OC Cyprinidae; Danio. OX NCBI_TaxID=7955; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Tuebingen; RG The Danio rerio sequencing project at the Sanger Institute; RL Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=AB; TISSUE=Skin; RG NIH - Zebrafish Gene Collection (ZGC) project; RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: NADH-cytochrome b5 reductases are involved in CC desaturation and elongation of fatty acids, cholesterol CC biosynthesis and drug metabolism (By similarity). CC -!- CATALYTIC ACTIVITY: NADH + 2 ferricytochrome b5 = NAD(+) + H(+) + CC 2 ferrocytochrome b5. CC -!- COFACTOR: FAD (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass membrane protein CC (Potential). CC -!- SIMILARITY: Belongs to the flavoprotein pyridine nucleotide CC cytochrome reductase family. CC -!- SIMILARITY: Contains 1 FAD-binding FR-type domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CR759887; CAM16402.1; -; Genomic_DNA. DR EMBL; BC122221; AAI22222.1; -; mRNA. DR IPI; IPI00786645; -. DR RefSeq; NP_001038825.1; -. DR UniGene; Dr.77055; -. DR Ensembl; ENSDARG00000051925; Danio rerio. DR GeneID; 751641; -. DR KEGG; dre:751641; -. DR ZFIN; ZDB-GENE-060825-83; zgc:153291. DR HOVERGEN; Q0P487; -. DR OMA; Q0P487; GMNKAMA. DR BRENDA; 1.6.2.2; 96826. DR Bgee; Q0P487; -. DR GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. DR GO; GO:0004128; F:cytochrome-b5 reductase activity; IEA:EC. DR GO; GO:0009055; F:electron carrier activity; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW. DR InterPro; IPR017927; Fd_Rdtase_FAD-bd. DR InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase. DR InterPro; IPR001834; NADH-Cyt_B5_reductase. DR InterPro; IPR008333; OxRdtase_FAD-bd. DR InterPro; IPR001433; OxRdtase_FAD/NAD_bd. DR Pfam; PF00970; FAD_binding_6; 1. DR Pfam; PF00175; NAD_binding_1; 1. DR PRINTS; PR00406; CYTB5RDTASE. DR PRINTS; PR00371; FPNCR. DR PROSITE; PS51384; FAD_FR; 1. PE 2: Evidence at transcript level; KW FAD; Flavoprotein; Lipid synthesis; Membrane; NAD; Oxidoreductase; KW Steroid biosynthesis; Sterol biosynthesis; Transmembrane. FT CHAIN 1 309 NADH-cytochrome b5 reductase 2. FT /FTId=PRO_0000287552. FT TRANSMEM 3 23 Potential. FT DOMAIN 48 160 FAD-binding FR-type. FT NP_BIND 140 170 FAD (By similarity). FT NP_BIND 179 214 FAD (By similarity). FT CONFLICT 199 199 I -> V (in Ref. 2; AAI22222). FT CONFLICT 207 207 F -> S (in Ref. 2; AAI22222). SQ SEQUENCE 309 AA; 34388 MW; 9EE4889EE66784F9 CRC64; MDILTAPVLI GVSIVVITVL YLFLKPAGSN STPPKPQNKI PKALQDPSVK YPLPLIEKEE INHDTKRFRF GLPSSSHVLG LPIGQHIYLS AKVNGSLVVR AYTPVSSDQD QGYVDLVVKV YYKNTHPSYP DGGKMSQYLD NMKIGDTIDF RGPNGLLVYN GKGKFAIRPD KKSEAEVRKF KHVAMIAGGT GITPMLQLIR SITADSFDET VCSLIFANQT EKDILLRNEL DEVHRNHPSK LKLWYTLDRP SEGWKYSEGF VNAAMMKDHL PPADSDVLVV MCGPPAMIEK ACLPNLLKLG YKKENIFAY //